Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.
All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.
Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.
Purpose-built solutions. Proven results. User & Patient-centered innovation.
Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity. Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.
We are the Innovation CRO.
Legacy of excellence. Proven execution. Patient impact accelerated.
In this conversation, Pablo Morales discusses his transition from a 16-year career at the FDA to joining Veranex, emphasizing his passion for medical device innovation and the importance of collaboration across disciplines. He shares insights on the lessons learned from his time at the FDA, the excitement of leading a diverse team, and the opportunities for transformation in medical device development, particularly through technology and regulatory strategies.
Key Takeaways:
Diversity of thought and expertise is critical for innovation in medical device development. Veranex is uniquely positioned to support innovators, because its diversity of thought spans the entire product development lifecycle.
Medical device success today isn’t just about innovation, it’s about integrating regulatory, clinical, and real-world evidence strategy from the start of development
Plan for the total product lifecycle, not just the initial submission. Integrate regulatory, clinical, and engineering strategy early to reduce delays and costly redesigns.
Patient-centered approaches and real-world evidence generation are key to transforming the industry.
